targomirs show promise in phase i study of malignant mesothelioma
Published 9 years ago • 114 plays • Length 8:36Download video MP4
Download video MP3
Similar videos
-
3:40
pembrolizumab showed clinical benefit in malignant pleural mesothelioma
-
18:08
new treatment avenues in malignant mesothelioma
-
32:29
clinical trials for mesothelioma | 2022 international symposium on malignant mesothelioma
-
32:21
advances in the treatment of malignant pleural mesothelioma
-
2:59
promise-meso: pembrolizumab vs. standard chemotherapy for mesothelioma
-
31:56
systemic therapies for mesothelioma | international symposium on malignant mesothelioma
-
5:00
promise-meso trial results: pembrolizumab vs chemotherapy for advanced pleural mesothelioma
-
4:37
first results of dream trial of frontline durvalumab for mesothelioma
-
2:18
dr. baas on the promise of immuno-oncology in mesothelioma
-
0:56
malignant mesothelioma
-
29:44
radiation therapy for mesothelioma | 2022 international symposium on malignant mesothelioma
-
30:35
fighting mesothelioma with genetics, tumor microenvironment, and the immune system | 2022 symposium
-
4:54
background of the keynote-158 trial for pembrolizumab in advanced mesothelioma
-
34:46
the role of surgery in malignant pleural mesothelioma - harvey pass, md
-
1:49:11
2023 symposium | pleural mesothelioma systemic treatment, surgery, clinical trials
-
26:21
what is mesothelioma?
-
6:19
emerging options for malignant pleural mesothelioma
-
2:39
mist: parp inhibitors for malignant mesothelioma
-
26:29
pleural mesothelioma treatment via surgical options - robert kratzke, md